The outcomes of cancer treatment in individuals born preterm can be influenced by their unique health challenges. Preterm infants often have ongoing health issues such as chronic lung disease and cognitive impairments, which can complicate cancer treatment and recovery. Additionally, their developing bodies may respond differently to chemotherapeutic agents and other treatments.
